Deal or no deal: How Europe's drugmakers are brokering prices with Trump

As the US president pressures pharma to cut costs and invest at home, European firms warn of lost 'health sovereignty'

Pro
Health
Euractiv
President Donald Trump is applauded as he signs a series of Executive Orders on lowering drug prices. [Photo by: Hum Images/Universal Images Group via Getty Image]

Want to keep reading?

Get a subscription on Euractiv Pro and elevate your political insight!

Discover Euractiv Pro For corporations

Already have an account?

More from this section

Biopharma backs Commission's push for venture capital
Pro

Health

Biopharma backs Commission's push for venture capital
Majority of USAID contraceptives stored improperly must be destroyed, says minister

Health

Majority of USAID contraceptives stored improperly must be destroyed, says minister
Sweden considers economic penalties for long healthcare queues

Health

Sweden considers economic penalties for long healthcare queues

Public Health

More
Ahead of COP11, EU governments still too close to tobacco industry
Pro

Health

Ahead of COP11, EU governments still too close to tobacco industry
EU fails to agree on common position ahead of COP11 on tobacco control
Pro

Health

EU fails to agree on common position ahead of COP11 on tobacco control
MEPs and drug regulator EMA seek way forward on male contraception
Pro

Health

MEPs and drug regulator EMA seek way forward on male contraception

Health Industry

More
EU pharma talks inch forward as negotiators eye December deal

Health

EU pharma talks inch forward as negotiators eye December deal
Big pharma data, EU stockpile: Parliament’s asks for the Critical Medicines Act
Pro

Health

Big pharma data, EU stockpile: Parliament’s asks for the Critical Medicines Act
Health committee pushes for tighter focus in Critical Medicines Act
Pro

Health

Health committee pushes for tighter focus in Critical Medicines Act